Correction to: Fibroblast growth factor receptor 3 alterations and response to immune checkpoint inhibition in metastatic urothelial cancer: a real world experience

Affiliations

¹ Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
² Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
³ GeneCentric Therapeutics, Inc., Durham, NC, USA.
⁴ Department of Urology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
⁵ Department of Urology, Loyola University, Chicago, IL, USA.
⁶ Department of Pathology and Laboratory Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
⁷ Department of Radiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
⁸ Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA. wykim@med.unc.edu.
⁹ Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA. wykim@med.unc.edu.
¹⁰ Department of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA. wykim@med.unc.edu.

^# Contributed equally.

Published Erratum

Tracy L Rose et al. Br J Cancer. 2022 May.

. 2022 May;126(8):1237.

doi: 10.1038/s41416-022-01781-y.

¹ Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
² Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
³ GeneCentric Therapeutics, Inc., Durham, NC, USA.
⁴ Department of Urology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
⁵ Department of Urology, Loyola University, Chicago, IL, USA.
⁶ Department of Pathology and Laboratory Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
⁷ Department of Radiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
⁸ Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA. wykim@med.unc.edu.
⁹ Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA. wykim@med.unc.edu.
¹⁰ Department of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA. wykim@med.unc.edu.

^# Contributed equally.

No abstract available

Erratum for

Fibroblast growth factor receptor 3 alterations and response to immune checkpoint inhibition in metastatic urothelial cancer: a real world experience.
Rose TL, Weir WH, Mayhew GM, Shibata Y, Eulitt P, Uronis JM, Zhou M, Nielsen M, Smith AB, Woods M, Hayward MC, Salazar AH, Milowsky MI, Wobker SE, McGinty K, Millburn MV, Eisner JR, Kim WY. Rose TL, et al. Br J Cancer. 2021 Oct;125(9):1251-1260. doi: 10.1038/s41416-021-01488-6. Epub 2021 Jul 22. Br J Cancer. 2021. PMID: 34294892 Free PMC article.